"Dihydroxyphenylalanine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
- beta Hydroxytyrosine
- 3 Hydroxy DL tyrosine
- 3,4 Dihydroxyphenylalanine
Below are MeSH descriptors whose meaning is more general than "Dihydroxyphenylalanine".
Below are MeSH descriptors whose meaning is more specific than "Dihydroxyphenylalanine".
This graph shows the total number of publications written about "Dihydroxyphenylalanine" by people in this website by year, and whether "Dihydroxyphenylalanine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Dihydroxyphenylalanine" by people in Profiles.
Lench DH, Keith K, Wilson S, Padgett L, Benitez A, Ramakrishnan V, Jensen JH, Bonilha L, Revuelta GJ. Neurodegeneration of the Globus Pallidus Internus as a Neural Correlate to Dopa-Response in Freezing of Gait. J Parkinsons Dis. 2022; 12(4):1241-1250.
Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, Kish SJ, Lange N, Langston JW, Marek K, Morin L, Moy C, Murphy D, Oertel WH, Oliver G, Palesch Y, Powers W, Seibyl J, Sethi KD, Shults CW, Sheehy P, Stoessl AJ, Holloway R. The role of radiotracer imaging in Parkinson disease. Neurology. 2005 Jan 25; 64(2):208-15.
Kalivas PW, Duffy P, DuMars LA, Skinner C. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J Pharmacol Exp Ther. 1988 May; 245(2):485-92.
Widerlöv E, Kalivas PW, Lewis MH, Prange AJ, Breese GR. Influence of cholecystokinin on central monoaminergic pathways. Regul Pept. 1983 May; 6(2):99-109.
Molinoff PB. The regulation of the noradrenergic neuron. J Psychiatr Res. 1974; 11:339-45.
Molinoff PB, Brimijoin S, Axelrod J. Induction of dopamine- -hydroxylase and tyrosine hydroxylase in rat hearts and sympathetic ganglia. J Pharmacol Exp Ther. 1972 Jul; 182(1):116-29.
Barker DL, Molinoff PB, Kravitz EA. Octopamine in the lobster nervous system. Nat New Biol. 1972 Mar 15; 236(63):61-3.
Whitsett TL, Halushka PV, Goldberg LI. Attenuation of postganglionic sympathetic nerve activity by L-dopa. Circ Res. 1970 Oct; 27(4):561-70.
Privitera PJ, Loggie JM, Gaffney TE. A comparison of the cardiovascular effects of biogenic amines and their precursors in newborn and adult dogs. J Pharmacol Exp Ther. 1969 Apr; 166(2):293-8.